1.. Introduction {#S0001}
================

Adverse childhood experiences (ACE) refer to traumatic experiences in childhood including physical abuse (physical assault, beatings), sexual abuse (unconsented sexual contact), and psychological abuse (threats, insults, humiliation), in addition to neglect (lack of support to primary basic needs) and adverse events in the family setting (parental death, divorce or institutionalization; substance abuse; mental illness; financial problems, and others) (Brown et al., [2010](#CIT0009)).

The consequences of ACE are not limited to the mental health of the individual, as shown by Scott et al. ([2008](#CIT0042)) and Goodwin and Wamboldt ([2012](#CIT0024)), but also affect physical health, appearing as risk factors for the onset of different medical conditions later in life (Afifi et al., [2016](#CIT0003); McCrory, Dooley, Layte, & Kenny, [2015](#CIT0034)). This may happen because, as described by Sonu, Post, and Feinglass ([2019](#CIT0047)), ACE trigger the experience of toxic stress, which in turn favours an increase in stress response that affects brain development, structure, and function and the physiology of other systems as the endocrine and immune systems. According to Clemens et al. ([2018](#CIT0011)), our knowledge about these mechanisms is still imprecise, but evidence has implicated different pathways that may act in isolation or in combined form, including HPA axis dysregulation and resulting cortisol increases, increased levels of pro-inflammatory cytokines, and socioeconomic and individual aspects that may favour risky or dysfunctional behaviours including smoking, alcohol and drug abuse, sexual promiscuity, inadequate diets, and sedentary lifestyle (Anda et al., [2008](#CIT0004); Felitti et al., [1998](#CIT0018); Gilbert et al., [2014](#CIT0022); Iniguez & Stankowski, [2016](#CIT0028); Kamiya, Timonen, & Kenny, [2016](#CIT0029); Scott et al., [2011](#CIT0043)). Furthermore, Sheikh ([2018a](#CIT0044)) and De Hert et al. ([2011](#CIT0015)) also emphasize the direct or indirect contribution of poor mental health to negative health outcomes (e.g. sedentary lifestyle, poor feeding habits, reduced self-care, and medication side effects).

Lung diseases stand out among the most common chronic diseases today due to the increase in their prevalence and their potential to cause disability in affected individuals, with important social and economic consequences (Brasil, [2010](#CIT0008)). Asthma and chronic obstructive pulmonary disease (COPD) are the most common respiratory diseases today. Prevalence data show that asthma affects around 334 million people worldwide. COPD affects over 200 million people, of which around 65 million have moderate or severe presentations of the disease, making it the third cause of death in the world. Mortality rates are estimated at around 3 million a year, with gradual annual increases (Forum of International Respiratory Societies, [2017](#CIT0021)).

Some studies have shown associations between ACE and the occurrence of different lung diseases (Cunningham et al., [2014](#CIT0013); Iniguez & Stankowski, [2016](#CIT0028); McCrory et al., [2015](#CIT0034)), whereas others have not confirmed this relationship (Afifi et al., [2016](#CIT0003); Llabre et al., [2017](#CIT0033)). Exley, Norman, and Hyland ([2015](#CIT0017)) performed a systematic literature review to investigate the specific association between asthma and ACE involving 10 studies with a total of 31.524 adults assessed. The authors concluded that exposure to violence early in life is related to increased susceptibility and sensitivity of the body to pro-inflammatory responses, which would in turn increase the risk of developing asthma.

Later, a non-systematic literature review investigated the relationship between child maltreatment and paediatric asthma, examining a total of seven studies. The results showed that abuse increased the risk of asthma and morbidity in adulthood and that this association appeared to depend on different variables including disease subtype, type of reported ACE, and form of ACE investigation (self-report *vs*. institutional records) (Schreier, Chen, & Miller, [2016](#CIT0040)).

To our knowledge, no study to date assessed the associations between ACE and lung diseases, except asthma. Also, we have found no meta-analysis on this topic. Therefore, the objective of this study was to perform a systematic review and meta-analysis to investigate risk factors for the development of chronic lung diseases in adulthood associated with ACE. This should contribute to encourage investigations on the subject, whether by expanding the variety of outcomes investigated or through the search for a combined quantitative measure based on statistically adequate methods.

2.. Method {#S0002}
==========

This was a systematic literature review based on the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (*PRISMA*; Liberati et al., [2009](#CIT0032)) statement and using the online databases *PubMed, PsycINFO*, and *Web of Science*, with no time or language limits.

The search terms used were *(Chronic Lung Diseases OR Asthma OR COPD OR Bronchitis OR Emphysema OR Lung Cancer OR Pulmonary Fibrosis) AND (Maltreatment OR Trauma OR Adverse Experiences OR Child Abuse OR Sexual Abuse OR Physical Abuse OR Emotional Abuse OR Negligence) AND (Childhood OR Infant OR Infancy OR Early)* and the last literature search for the review was performed on 27 November 2019.

The review included clinical studies using quantitative methods, involving human samples of both sexes, and with the objective of assessing risk indicators associated with exposure to ACE and the development of lung diseases in adulthood. The exclusion criteria and the complete process of article search and selection are shown in [Figure 1](#F0001).10.1080/20008198.2020.1720336-F0001Figure 1.Flow diagram of the process of article search and selection for the meta-analysis based on the PRISMA protocol (Liberati et al., [2009](#CIT0032)).

The following criteria were used for the meta-analysis: (1) independent variable: any ACE (physical, sexual or emotional) assessed in isolated or combined form; (2) dependent variable: any lung disease assessed in isolation or together with other lung diseases; (3) measure of odds ratios (OR) related to the presence/absence of ACE preferably adjusted in relation to smoking (isolated or combined with other risk factors for physical and mental health) or, when smoking was absent, in relation to the subjects' socio-demographic characteristics (note: the review included studies in which results were expressed in terms of OR or where the raw data published in the study or obtained through contact with the authors allowed the calculation of OR).

The eligibility of the studies to be included in the review was determined independently by two mental health professionals with experience in consultation-liaison psychiatry and by a statistician, with divergences resolved by consensus. The extraction of data from the articles was based on a standard form created by the authors that included the following data: (a) country of origin of the study, year of publication, and methodological design; (b) sample size; (c) subjects' sex, age, and educational level; (d) lung disease of interest, source of diagnostic information, and instrument used for the assessment of ACE; and (e) data for the calculation of effect sizes (OR).

The methodological quality of the studies was assessed with the Newcastle-Ottawa Quality Assessment Scale (Peterson, Welch, Losos, & Tugwell, [2011](#CIT0035)) that measure methodological quality according to three parameters: sample selection (four items), comparability (two items), and exposure (three items).

Fixed- and random-effect models were used in the estimation of meta-analytical measures, and the method of DerSimonian and Lair was used in the random-effect model (Higgins, Thompson, Deeks, & Altman, [2003](#CIT0026)). The fixed-effects model assumes that differences observed across the studies are due only to sampling errors, that is, to chance. The random-effects model, in turn, considers that the studies included in a meta-analysis form a random sample from a hypothetic population of studies and that, although their effects are not considered equal, they are connected through a probability distribution generally assumed as normal. Random-effects models are desirable when the heterogeneity across studies is high, as they offer combined results with greater confidence intervals (Santos & Cunha, [2013](#CIT0039)). Data on the accuracy indicators of each study and meta-analytical measures are presented in Forest plots below.

The heterogeneity across studies was assessed with I^2^ statistics and Cochran's Q test. I^2^ statistics is interpreted as the total percentage of variation across the studies included in a meta-analysis. Higgins et al. ([2003](#CIT0026)) suggested a scale in which I^2^ values close to 0% indicate no heterogeneity across studies; values around 25% indicate low heterogeneity; values around 50% indicate moderate heterogeneity; and values around 75% indicate high heterogeneity across studies. All the analyses and graphs were made with the software *Stata* v. 13.

3.. Results {#S0003}
===========

A total of 19 studies were included in the meta-analysis. In respect to their methodological quality, 63% fulfilled at least two-thirds of the requirements and the main critical points found were related to the scarcity of information on the definition of cases, estimation of exposure by self-report, and absence of no-response rates. Details about these data are presented in Supplementary Material S1.

Data about the samples and study designs of the articles included in the review are presented in [Table 1](#T0001).10.1080/20008198.2020.1720336-T0001Table 1.Sample and methodological characterization of the studies analysed and included for the meta-analysis (N = 19).Autor/YearCountryN Sample\
(♂/♀)Age (years)\
$\overset{‾}{x}$ (DP) or (min-max)EducationStudy Design/Data SourceOutcomeClinical DiagnostcACE MeasuresRomans, Belaise, Martin, Morris, and Raffi ([2002](#CIT0037))New Zealand354 ♀26--70NICross-sectional Retrospective/Randon community-based sampleAsthmaSRDSWainwright, Surtees, Wareham, and Harrison ([2007a](#CIT0051))United Kingdom9081 ♂ 11,807 ♀41 -- 80NICross-sectional Study/NCEPICAsthmaSRDSScott et al. ([2008](#CIT0042))America,\
Europe, Asia7394 ♂ 10,909 ♀21 -- 98NICross-sectional Population Survey/WMHSAsthmaSRDSCoogan et al. ([2013](#CIT0012))United States28,456 ♀21 -- 6949% COLProspective cohort/BWHSAsthmaSRDSGilbert et al. ([2014](#CIT0022))United States21,322 ♂ 32,676 ♀≥ 1837,8% COLCross-sectional Population Survey/BRFSSAsthmaSRDSSantaularia et al. ([2014](#CIT0038))United States8160 ♀≥ 18NICross-sectional Survey/Kansas BRFSSAsthmaSRDSFelitti et al. ([1998](#CIT0018))United States3859 ♂ 4197 ♀$\overset{‾}{x}$ = 56,143,4% COLCross-sectional Population Survey/KPSDHACCOPDSRDSSpringer ([2009](#CIT0048))United States3317 ♂♀$\overset{‾}{x}$ = 53,8NICross-sectional Population Survey/WLSCOPDSRCTSCunningham et al. ([2014](#CIT0013))United States19,015 ♂ 26,546 ♀≥ 1835,8% COLCross-sectional Population Survey/BRFSSCOPDSRDSBrown et al. ([2010](#CIT0009))United States7970 ♂\
9367 ♀≥ 1839,3% COLProspective cohort/KPSDHACLung CancerHRCTSAnda et al. ([2008](#CIT0004))United States7117 ♂\
8355 ♀$\overset{‾}{x}$ = 56 (±15)40% COLProspective cohort/ACE Study CohortLung Disease\
(Asthma + Bronchitis + Emphysema)SR\
HRCTSDowney et al. ([2017](#CIT0016))United States2541 ♂\
3820 ♀≥ 1830,5%\
COLCross-sectional Population Survey/BRFSSLung Disease (Bronchitis + Emphysema+COPD)SRDSScott, Smith, and Ellis ([2012](#CIT0041))New Zealand599 ♂\
814 ♀$\overset{‾}{x}$ = 2247,7% HSCross-sectional Survey/NZMHSAsthmaSRDSAfifi et al. ([2016](#CIT0003))Canada23,395 ♂♀≥ 18NICross-sectional Survey/CCHSAsthma\
COPDSRCEVQAbajobir et al. ([2017](#CIT0001))Australia1783 ♂\
1979 ♀≥ 18NIProspective Cohort/MUSPAsthmaSR+LFSWCPRBanerjee, Gelaye, Zhong, Sanchez, and Williams ([2018](#CIT0006))Peru3081 ♀≥ 18NICross-sectional Survey/Outpatient from Intitution for Maternal PerinatalAsthmaSRCPSAQLlabre et al. ([2017](#CIT0033))United States2260 ♂\
2746 ♀18 -- 74NICross-sectional Study/HCHSLAsthma\
COPDSRDSGoodwin, Wamboldt, and Pine ([2003](#CIT0025))United States5877 ♂♀18 -- 54NICross-sectional Population Survey/NCSLung Disease\
(Asthma + Bronchitis + Tuberculosis)SRDSKamiya et al. ([2016](#CIT0029))Ireland8178 ♂♀≥ 50NICross-sectional Population Survey/ILSALung Disease\
(Asthma+COPD)SRDS[^1]

The studies were carried out mainly in the USA (n = 11). Together, they included a total of 276,975 subjects, with the smallest sample consisting of 354 and the largest of 53,998 subjects ($\overset{ˉ}{x}$**=**14577, SD = 14.8; median = 8160). The age of participants ranged between 18 and 98 years, with a predominance of adults aged 45--65 years and of mixed-sex samples (79%). In respect to the design, most were population studies with a cross-sectional design (n = 15) and used data from previous investigations or databases (n = 14). Information about the educational level of subjects was lacking in most of the articles.

Concerning the clinical outcomes of interest, 58% of the studies investigated asthma alone (n = 11), 26% investigated COPD (encompassing bronchitis and emphysema; n = 5) and 21% investigated the presence of lung conditions in general without distinguishing between them (n = 4). Only one study investigated lung cancer as an outcome.

The assessment of the clinical status (presence or absence of lung disease) was based only on self-report in most studies (n = 16). Only two studies were based on medical records and one included an assessment of lung function to complement diagnostic measures.

For the assessment of ACE, around 68% of the studies (n = 13) used non-validated instruments developed specifically for the study. Six studies used validated instruments to assess ACE, the most common of which was the Conflict Tactics Scale (Straus & Gelles, [1990](#CIT0049)). One study used data from child protection institutional records to assess child abuse.

The quantitative data related to the association between ACE and risk indicators for the development of lung diseases are presented in Supplementary Material S2. Data for the meta-analysis were extracted from this dataset and the results of the meta-analysis are presented in [Figure 2](#F0002).10.1080/20008198.2020.1720336-F0002Figure 2.Odds ratio for the presence of lung diseases in adulthood associated with ACE \[(A) Forest plot of isolated and combined measures -- random (D + L) and fixed (I-V) effects.

[Figure 2](#F0002) shows that 71.4% of the studies found statistically significant associations between ACE and lung diseases. The combined measures also revealed that ACE were associated with the presence of lung diseases in adulthood (random effect: OR = 1.41; CI 95%: 1.28 to 1.54; fixed effect: OR = 1.18; CI 95%: 1.15 to 1.21). The analyses showed a marked heterogeneity across studies (I^2^ = 88.5%). For further details, please see Supplementary Material S3.

Subgroup analyses for specific lung diseases were performed separately considering the clinical outcomes asthma (n = 11) and COPD (n = 5), regardless of ACE subtype. Combined results were positive for both asthma (random effect: OR = 1.32; CI 95%: 1.13 to 1.50) and COPD (random effect: OR = 1.44; CI 95%: 1.13 to 1.76) and, differently than expected, the rate of heterogeneity across studies was higher (I^2^ = 90.1% for asthma and I^2^ = 91.5% for COPD). For more details, please see Supplementary Material S4.

Subgroup analyses were then performed to assess the mediating effect of smoking separately. The combined results were positive for both conditions (adjusted to smoking -- 9 studies: random effect: OR = 1.06; CI 95%: 1.02 to 1.10; I^2^ = 30.5%; not adjusted to smoking -- 12 studies: random effect: OR = 1.53; CI 95%: 1.38 to 1.67; I^2^ = 75.5%); however, this result becomes less expressive when the adjustment is considered (see [Figure 2](#F0002)).

4.. Discussion {#S0004}
==============

The results of the meta-analysis show that people who have gone through ACE have around 40% more chance of presenting a lung disease in adulthood compared to unaffected individuals. However, when other risk factors for the development of lung diseases are taken into consideration, such as smoking, this risk is greatly decreased, becoming weak and challenging the hypothesis that a direct relationship exists between childhood trauma and the occurrence of lung diseases.

According to the extant literature, the physiopathological mechanisms more likely to underlie the relationship between ACE and the aetiology of different chronic diseases refer to organic reactions that occur in response to chronic psychosocial stress. Thus, chronic exposure to stress would lead to structural and functional abnormalities in the nervous, endocrine, and immune systems, which work in concert to react to stress. This negative exposure would trigger specialized adaptive responses that include the activation of different brain areas and of the sympathetic nervous system and lead to inflammatory processes, eventually triggering the neuroendocrine response to stress and the activation of the hypothalamic-pituitary-adrenal (HPA) axis. Although these integrated systems are efficient in generating short-term adaptation to acute stress, their lasting stimulation may have detrimental effects on the organism (Danese & McEwen, [2012](#CIT0014)). Acute stress is associated with an increase in cortisol levels that results in the suppression of inflammatory responses. Under the influence of stressors such as ACE, HPA axis function could be altered, leading to a decrease in cortisol levels and an increase in inflammatory markers that would favour the susceptibility to chronic diseases.

This could occur even in the absence of harmful lifestyle choices or conditions, such as sedentary lifestyle, smoking or unemployment, for example (Afifi et al., [2016](#CIT0003); Anda et al., [2008](#CIT0004); Danese & McEwen, [2012](#CIT0014)). However, our data show that the mediating effect of different risk factors in this relationship, mainly smoking, is quite expressive. As reported by Campbell, Walker, and Egede ([2016](#CIT0010)) and Ford et al. ([2011](#CIT0020)), victims of ACE are at increased vulnerability to becoming smokers (2.2--2.7 times). Earlier, Anda et al. ([1999](#CIT0005)) described relevant relationships between the number of ACE and early onset of smoking, prevalence of smoking in adulthood (especially heavy smoking), and prevalence of self-reported COPD. These findings seem to reflect the late consequences of adverse coping methods such as smoking, food and drug abuse, and promiscuity. To Anda et al. ([1999](#CIT0005)) and Brown et al. ([2010](#CIT0009)), smoking may act as a resource related to self-esteem to alleviate emotional wounds or even as a surrogate treatment for psychological/affective symptoms based on the psychoactive effects of nicotine.

The subgroup analyses that considered the risk for asthma and COPD separately did not show expressive differences between the two conditions. This is an interesting finding if we consider the aetiology of the conditions since one could expect the risks for their occurrence to be different. In asthma, the most common aetiological factors described are related to physiological responses to the exposure to environmental allergens, air pollution, lower respiratory tract infections in early life, and abnormal immune responses (Forum of International Respiratory Societies, [2017](#CIT0021)). In COPD, however, harmful habits such as smoking, for example, play a major role as they favour the destruction of lung tissue and the obstruction of small airways by inflammation and mucus (Felitti et al., [1998](#CIT0018); Forum of International Respiratory Societies, [2017](#CIT0021); Llabre et al., [2017](#CIT0033); Springer, [2009](#CIT0048)).

Our findings suggest, therefore, that regardless of the type of lung disease and their aetiological specificities, the impact of ACE is relevant in the assessment of risk, whether through direct or indirect action on this outcome. Despite our attempt to group studies to perform quantitative analyses of the risk indicators adjusted for confounding/mediating variables, this was limited by the heterogeneity of studies and the lack of data for the inclusion of other studies in the meta-analysis. In the investigation about the effects of mediating variables, we opted to prioritize smoking due to its direct connection with the aetiology of lung diseases and to the fact that this variable was controlled for in most studies. Although the heterogeneity across studies in this subgroup was the lowest observed, it should be noted that smoking was controlled together with a number of other health conditions and risk behaviours, and not in isolation. This is a limitation of our study and future investigations to confirm this finding and elucidate specific influences of smoking in the vulnerability to lung diseases are opportune, as well as studies about other variables including the presence of mental disorders, the lack of emotional support, or conditions of access to health, for example, which would favour the accurate design of prevention and harm reduction programmes.

An additional limitation of our study was the impossibility to assess the different types of ACE separately in order to check their impact on the occurrence of lung diseases in adulthood. This could be important since previous studies have suggested that sexual abuse and adverse events in the family setting, as well as a high incidence (\>4) of traumatic experiences, are associated with increased risk of respiratory diseases in both smokers and non-smokers (Cunningham et al., [2014](#CIT0013); Remigio-Baker, Hayes, & Reyes-Salvail, [2015](#CIT0036); Shields, Hovdestad, Gilbert, & Tonmyr, [2016](#CIT0046)).

The studies reviewed here also had methodological limitations that deserve attention in future investigations: (a) almost all studies had a cross-sectional design, which hinder conclusions about causes and effects that could be possible with the adoption of a longitudinal design; (b) in all studies, the association between ACE and lung diseases was assessed as a secondary outcome of previous population studies and, therefore, were based on methods that were not originally designed for this specific purpose, resulting in decreased methodological quality; (c) data related to ACE were investigated through non-validated instruments and the assessment of clinical outcomes was not based on objective diagnostic tools (e.g. clinical examination), which favours heterogeneity and restrain analyses.

Additional limitations inherent to the investigation of ACE include the use of retrospective information, with the increased possibility of recall biases, especially if we consider the emotionally distressing nature of such experiences (Afifi et al., [2016](#CIT0003); Downey, Gudmunson, Pang, & Lee, [2017](#CIT0016); Goodwin & Wamboldt, [2012](#CIT0024)). Another issue to be considered is that almost all studies were conducted in Europe and North America, where better socio-economic and educational conditions reflect on the prevalence and impact of ACE (Abramovay, Castro, Pinheiro, Lima, & Matinelli, [2002](#CIT0002)). Thus, the results described here cannot be generalized to underdeveloped or developing countries, where specific studies should be conducted.

In conclusion, ACE are important risk factors for lung diseases in adulthood, which highlights the importance of increasing awareness among health professionals about the early detection and intervention in situations of risk or vulnerability in childhood.
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[^1]: BL: Basic Level; BRFSS: Behaviour Risk Factor Surveillance Survey; BWHS: Black Women's Health Study; CCHS: Cannadian Community Health Survey; CEVQ: Childhood Experiences of Violence Questionnaire; CPSAQ: Childhood Physical and Sexual Abuse Questionnaire; COPD: Chronic Obstrutive Pulmonar Disease; COL: College; CTQ: Childhood Trauma Questionnaire; CTS: Conflict Tatics Scale; DCFS: Department of Child and Family Services; DS: Developed for Study; HCHSL: Hispanic Community Health Study of Latinos; HR: Hospital Records; HS:High School; HSS: Health and Social Support; ILSA: Irish Longitudinal Study on Ageing; IR: Institutional Register; KPSDHAC: Kaiser Permanente's San Diego Health Appraisal Clinic; LF: Lung Function; LT: Lung Transplantation; MIDUS: Midlife Development in the United States; MP: Medications Prescription; NCEPIC: Norfolk Cohort of the European Prospective Investigation Into Cancer; NCS: National Comorbidy Survey; NZMHS: New Zealand Mental Health SurveyMESA: Marshfiled Epidemiologic Study Area; RCMHC: Rural Community Mental Health Centre; SR: Self Reported; SWCPR: State Wide Child Protection Records; WLS: Winconsin Longitudinal Study; WMHS: World Mental Health Survey.
